Randomized phase II study of WT1 peptide vaccine plus gemcitabine for advanced pancreatic ductal adenocarcinoma (PDAC): Clinical efficacy and immune response
Abstract only
Saved in:
| Published in | Journal of Clinical Oncology Vol. 34; no. 15_suppl; p. 3085 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English Japanese |
| Published |
American Society of Clinical Oncology (ASCO)
20.05.2016
|
| Online Access | Get full text |
| ISSN | 0732-183X 1527-7755 |
| DOI | 10.1200/jco.2016.34.15_suppl.3085 |
Cover
| Summary: | Abstract only |
|---|---|
| ISSN: | 0732-183X 1527-7755 |
| DOI: | 10.1200/jco.2016.34.15_suppl.3085 |